0.02Open0.05Pre Close20 Volume690 Open Interest22.00Strike Price57.00Turnover7663.38%IV20.32%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type0.0410Delta0.0470Gamma610.33Leverage Ratio-119.7091Theta0.0000Rho25.05Eff Leverage0.0000Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet